EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in the treatment of Alzheimer’s disease

Rezzan Temelli Goceroglu, Ahmet Hacimuftuoglu

Frontiers in Pharmacology · 17.06.2026 · 17

DOI: 10.3389/fphar.2026.1819165 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 17.06.2026. Verfasst von Rezzan Temelli Goceroglu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Türkiye. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 312 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s Disease (AD) is a progressive neurodegenerative disease for which disease-modifying therapies remain limited. Despite extensive efforts targeting amyloid-β and tau, these approaches have not translated into clear clinical benefit, underscoring the need for a more integrated understanding of AD pathogenesis. This narrative review summarizes recent advances in the molecular mechanisms underlying AD and evaluates current and emerging therapeutic strategies. A literature search was conducted using PubMed, Google Scholar, Web of Science and Scopus, focusing on preclinical and clinical studies addressing AD pathophysiology and treatment development. Conclusion: We summarize key pathogenic pathways, including Aβ aggregation, tau hyperphosphorylation, neuroinflammation, synaptic dysfunction, and metabolic dysregulation, and discuss how these interconnected processes have informed drug development efforts. Particular attention is given to limitations of single-target approaches and the growing interest in multi-target and combination therapies. In conclusion, a better understanding of the pathological mechanisms underlying AD may contribute to the development of more effective pharmacological therapies and integrated therapeutic approaches targeting the multifactorial nature of the disease.

Schlagwörter

Stichwörter der Autor:innen

alzheimer’s diseaseclinical trialsdisease-modifying therapiespathophysiologypreclinical trialsrisk factorstreatment

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Türkiye.
  • Department of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum, Türkiye.

Zitieren

APA

Temelli Goceroglu, R., & Hacimuftuoglu, A. (2026). Advances in the treatment of Alzheimer’s disease. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1819165

Vancouver

Temelli Goceroglu R, Hacimuftuoglu A. Advances in the treatment of Alzheimer’s disease. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1819165

BibTeX
@article{TemelliGoceroglu2026,
  author = {Temelli Goceroglu, Rezzan and Hacimuftuoglu, Ahmet},
  title = {Advances in the treatment of Alzheimer’s disease},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1819165}
}
Kostenlos starten →